The Wire
What companies filed, as it lands
Newest first, by when each filing was accepted. Form 4 rows are open-market purchases and sales.
- 15:00Core sessionESEAEuroseas LTDThe Chief Financial Officer sold $357K of stock.Form 4Filing ↗
- 14:47Core sessionEDRYEuroDry LtdThe Chief Financial Officer sold $166K of stock.Form 4Filing ↗
- 14:44Core sessionRMBSRambus IncA director sold $555K of stock under a 10b5-1 plan.Form 4Filing ↗
- 14:28Core sessionVKQInvesco Municipal TrustTimothy M O'Reilly sold $91K of stock.Form 4Filing ↗
- 14:07Core sessionCZNCCitizens & Northern CorpA director bought $204 of stock.Form 4Filing ↗
- 14:03Core sessionCZNCCitizens & Northern CorpA director bought $6K of stock.Form 4Filing ↗
- 13:14Core sessionMKC-VMcCormick & Co IncA director bought $45K of stock.Form 4Filing ↗
- 12:55Core sessionANGIAngi IncPassive stake of 5% or more (13G), filed by BlackRock Portfolio Management.13GFiling ↗
- 12:48Core sessionYHGJYunhong Green Cti LTDMaterial agreement and director nominations.8-K 1.01Filing ↗
- 12:45Core sessionAMODAlpha Modus Holdings, IncOfficer or director change.8-K 5.02Filing ↗
- 12:42Core sessionOWLSObook Holdings IncPassive stake of 5% or more (13G), filed by SBI Digital Asset Holdings Co.13GFiling ↗
- 12:37Core sessionCECOCeco Environmental CorpRegulation FD disclosure and listing notice or transfer.
CECO Environmental to Transfer U.S. Stock Exchange Listing to the Texas Stock Exchange Common stock expected to begin trading on TXSE on October 19, 2026, under existing ticker symbol “CECO”
8-K 3.01Filing ↗ - 12:28Core sessionOKEONEOK IncPassive stake of 5% or more (13G), filed by BlackRock.13GFiling ↗
- 12:26Core sessionNBISNebius Group N.V.The Chief Infrastructure Officer sold $6.8M of stock.Form 4Filing ↗
- 12:25Core sessionSTAAStaar Surgical CoOfficer or director change and Regulation FD disclosure (amended).
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer The architect of STAAR's global refractive transformation returns to lead STAAR's next commercial chapter as EVO ICL outpaces…
8-K/A 5.02Filing ↗ - 12:12Core sessionBBDBank BradescoA director bought $5.8M of stock.Form 4Filing ↗
- 12:02Core sessionWVVIWillamette Valley Vineyards IncThe Chief Executive Officer bought $19K of stock.Form 4Filing ↗
- 11:58Core sessionKRMNKarman Holdings IncPassive stake of 5% or more (13G), filed by BlackRock.13GFiling ↗
- 11:54Core sessionSBRSabine Royalty TrustResults of operations.
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR OCTOBER 2026
8-K 2.02Filing ↗ - 11:50Core sessionPDXPIMCO Dynamic Income Strategy FundSaba Capital Management, a 10% owner, sold $929K of stock.Form 4Filing ↗
- 11:47Core sessionGISGeneral Mills IncThe Segment President sold $197K of stock.Form 4Filing ↗
- 11:45Core sessionNBISNebius Group N.V.The Chief Technology Officer sold $3.4M of stock.Form 4Filing ↗
- 11:12Core sessionMXFMexico Fund IncSaba Capital Management, a 10% owner, bought $389K of stock.Form 4Filing ↗
- 10:57Core sessionGRXGabelli Healthcare & WellnessRx TrustSaba Capital Management, a 10% owner, bought $59K of stock.Form 4Filing ↗
- 10:55Core sessionKRKroger CoOther events.8-K 8.01Filing ↗
- 10:54Core sessionNBISNebius Group N.V.The CEO sold $8.8M of stock.Form 4Filing ↗
- 10:47Core sessionGLBEGlobal-E Online LtdThe CEO sold $978K of stock under a 10b5-1 plan.Form 4Filing ↗
- 10:46Core sessionGLBEGlobal-E Online LtdThe President sold $586K of stock under a 10b5-1 plan.Form 4Filing ↗
- 10:43Core sessionVICRVicor CorpThe Chairman & CEO sold $6.3M of stock under a 10b5-1 plan.Form 4Filing ↗
- 10:35Core sessionECATBlackRock ESG Capital Allocation Term TrustSaba Capital Management, a 10% owner, sold $47K of stock.Form 4Filing ↗
- 10:25Core sessionPYXSPyxis Oncology, IncPassive stake of 5% or more (13G), filed by Coastlands Capital.13GFiling ↗
- 10:21Core sessionBBDBank BradescoA director bought $33.6M of stock.Form 4Filing ↗
- 10:03Core sessionCHSCLCHS IncOfficer or director change.8-K 5.02Filing ↗
- 09:41Core sessionNEUPNeuphoria Therapeutics IncPassive stake of 5% or more (13G), filed by AdvisorShares Trust.13GFiling ↗
- 09:40Core sessionPBMPsyence Biomedical LTDPassive stake of 5% or more (13G), filed by AdvisorShares Trust.13GFiling ↗
- 09:35Core sessionSTRLSterling Infrastructure, IncRegulation FD disclosure.
Sterling Appoints Katherine Hargis as Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary
8-K 7.01Filing ↗ - 09:25Pre-marketDUOTDuos Technologies Group, IncMaterial agreement and acquisition or sale of assets completed.
Duos Technologies Sells Its GPU-as-a-Service Entity to Axe Compute, Accelerating Its Shift to a Pure-Play AI Colocation Platform Sale removes approximately $98.1 million of prospective equipment…
8-K 1.01Filing ↗ - 09:21Pre-marketSNPSSynopsys IncOther events.
Synopsys Initiates $1 Billion Accelerated Share Repurchase Agreement
8-K 8.01Filing ↗ - 09:20Pre-marketAGCOAgco CorpOfficer or director change.8-K 5.02Filing ↗
- 09:20Pre-marketNMTCNEUROONE MEDICAL TECHNOLOGIES CorpResults of operations and other events.
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million Preliminary Full-Year…
8-K 2.02Filing ↗ - 09:16Pre-marketROADConstruction Partners, IncRegulation FD disclosure.
Construction Partners, Inc. Completes Texas Acquisition Company Adds Two Hot-Mix Asphalt Plants in Growing Abilene Market
8-K 7.01Filing ↗ - 09:16Pre-marketEBSEmergent BioSolutions IncThe SVP, Products Business sold $20K of stock under a 10b5-1 plan.Form 4Filing ↗
- 09:08Pre-marketSKYHSky Harbour Group CorpThe Chief Financial Officer bought $36K of stock.Form 4Filing ↗
- 09:07Pre-marketIRTCiRhythm Holdings, IncRegulation FD disclosure.8-K 7.01Filing ↗
- 09:01Pre-marketCVXChevron CorpOfficer or director change.8-K 5.02Filing ↗
- 09:00Pre-marketLGLLGL Group IncOfficer or director change.8-K 5.02Filing ↗
- 09:00Pre-marketSQFTPresidio Property Trust, IncOther events.
Presidio Property Trust Announces Expiration and Results of Exchange Offer for All Outstanding Shares of its Series D Preferred Stock
8-K 8.01Filing ↗ - 09:00Pre-marketVIDAVIDA Global IncRegulation FD disclosure.
Vida Introduces Outcome-Based Billing for AI Agents New Pricing Model Charges Businesses for Results, Not Usage
8-K 7.01Filing ↗ - 09:00Pre-marketUXINUxin LtdThe Chief Executive Officer bought $7K of stock.Form 4Filing ↗
- 09:00Pre-marketPMVPPMV Pharmaceuticals, IncOfficer or director change and Regulation FD disclosure.
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors Dr. Eckler brings more than two decades of combined experience in healthcare investing across public and private markets at…
8-K 5.02Filing ↗